Haemangiopericytoma is a rare soft tissue tumour originating from the contractile pericapillary cells. Relatively little is known about its molecular pathogenesis. To address this issue, the insulin-like growth factor family (IGFs) was analysed in 19 tumours collected from a human tumour bank networ
Insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the platelet-derived growth factor receptor
✍ Scribed by Tiziana Deangelis; Andres Ferber; Renato Baserga
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 971 KB
- Volume
- 164
- Category
- Article
- ISSN
- 0021-9541
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
R^−^ cells are 3T3‐like cells derived from mouse embryos in which the insulin‐like growth factor I (IGF‐I) receptor (IGF‐IR) genes have been disrupted by targeted homologous recombination. These cells cannot grow in serum‐free medium supplemented by the growth factors that sustain the growth of other 3T3 cell lines, and cannot be transformed by oncogenes that easily transform wild type mouse embryo cells. We have used these cells to study the role of the IGF‐IR in the growth and transformation of cells overexpressing the platelet‐derived growth factor (PDGF)‐b̃b̃ receptor. We report that an overexpressed PDGF‐b̃b̃ receptor fails to induce mitogenesis or transformation in cells lacking the IGF‐IR, while capable of doing so in cells expressing the IGF‐IR. We conclude that the ability of the activated PDGF‐b̃b̃ receptor to stimulate cell proliferation and transformation requires a funcitional IGF‐IR. © 1995 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
Insulin-like growth factor I1 is believed to play an important role in fetal growth and development. The insulin-like growth factor I1 gene expression is tissue specific and developmentally regulated. We have previously shown an enhanced level of insulin-like growth factor I1 messenger RNA and prote
## Abstract Platelet‐derived growth factor (PDGF) and transforming growth factor β (TGF‐β), potent modulators of mesenchymal cell growth and differentiation, are often colocalizable in vivo. Previous in vitro studies in fibroblastic cell lines have shown variable, even antagonistic effects of TGF‐β
## Abstract ## BACKGROUND High concentrations of insulin‐like growth factor (IGF)‐I and IGF‐II have been demonstrated in human colonic adenocarcinomas and exert mitogenic effects through paracrine/autocrine interactions with the IGF‐I receptor (IGF‐IR). However, definitive studies of IGF‐IR expres